Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-302-7 | CAS number: 80-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4 May - 1 June 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions (not performed according to GLP).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 1,1,3,3-tetramethylguanidine
- EC Number:
- 201-302-7
- EC Name:
- 1,1,3,3-tetramethylguanidine
- Cas Number:
- 80-70-6
- Molecular formula:
- C5H13N3
- IUPAC Name:
- N,N,N',N'-tetramethylguanidine
- Details on test material:
- - Name of test material (as cited in section 1): 1,1,3,3-Tetramethylguanidine
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:(WI)BR strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate, Kent, UK
- Age at study initiation (LD50 study): between 6 and 10 weeks
- Weight at study initiation (LD50 study): 133 - 160 g (males), 131-159 g (females)
- Fasting period before study: yes, overnight fasting before the study
- Housing: in groups of 4 by sex (screening study) or in groups of 5 by sex and dose group (LD 50 study) in solid floor polypropylene cages
- Diet: SQC Rat and Mouse Maintenance Diet No. 1, modified, expanded (Special Diets Services Ltd., Stepfield, Witham, Essex, UK), ad libitum
- Water: mains water, ad libitum
- Acclimation period (LD50 study): 4 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 22
- Humidity (%): 42 - 59
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:
- Screening study: 5, 25, 125 and 500 mg/mL
- LD50 study: 40, 56.6, 80 and 113.1 mg/mL
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- - Screening study: 50, 250, 1250 and 5000 mg/kg bw
- LD50 study: 400, 566, 800 and 1131 mg/kg bw - No. of animals per sex per dose:
- - Screening study: 1 male and 1 female animal
- LD50 study: 5 male and 5 female animals - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
All animals were observed for overt signs of toxicity or behavioural change at 1/4, 1, 2 and 4 hours after treatment and subsequently once daily for 14 days. All gross or visible toxic or pharmacological effects were recorded. Individual body weights were recorded on the day before treatment (day-1), on the day of treatment, 7 and 14 days after treatment and at death.
- Necropsy of survivors performed: All animals dying during the working day and sick animals at the end of the study were subjected to gross necropsy. No tissues were retained. Animals surviving until the end of the study were sacrificed by exposure to high levels of carbon dioxide.
Screening study:
The animals were observed for mortality only. Frequent observations were made during 48 hours after treatment. Individual body weights were recorded on the day of treatment to allow the calculation of individual treatment volumes. No necropsies were performed in this study. The animals were killed after 48 hours. - Statistics:
- The acute oral median lethal dose (LD50) and 95% fiducial limits for combined male and female groups were calculated using a probit analysis (Finney D.J. (1964), Statistical Method for Biological Assay, 2nd Edition, London, Charles Griffin). Separate LD50 values and 95% fiducial limits were calculated for male and female animals.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 835 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 738 - 944
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 794 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 725 - 869
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 895 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 738 - 1 086
- Mortality:
- One male treated with 800 mg/kg bw was found dead 1 hour after treatment. One male treated with 800 mg/kg bw and one female treated with 1131 mg/kg bw were found dead 4 hours after treatment. All other deaths with 2 exceptions were noted 24 or 48 hours after treatment. Two females treated with 800 mg/kg bw were found dead 7 and 12 days after treatment, respectively.
See also Table 1 under "any other information on results". - Clinical signs:
- other: Animals treated with 400 mg/kg bw appeared normal throughout the study period. Only male animals treated with 566 mg/kg bw showed overt signs of toxicity. These signs, most pronounced during the day of dosing were lethargy, red staining around nose and m
- Gross pathology:
- The major pathological findings noted at necropsy were associated with the stomach, gastrointestinal tract and lungs. Data on the irritancy of the test article and the extreme alkalinity of the test article formulations suggest a severe irritant or corrosive effect on the intestinal linings and tissues with the delayed deaths being possibly due to resultant peritonitis.
Any other information on results incl. tables
Table 1. Acute oral toxicity.
Dose [mg/kg bw] |
Mortality |
Clinical signs |
|
N* |
N* |
Males |
||
400 |
0/5 |
0/5 |
566 |
0/5 |
5/5 |
800 |
3/5 |
5/5 |
1131 |
5/5 |
5/5 |
Females |
||
400 |
0/5 |
0/5 |
566 |
0/5 |
0/5 |
800 |
2/5 |
5/5 |
1131 |
4/5 |
5/5 |
*N = Number of animals / number of animals used
Table 2. Screening study.
Dose [mg/kg bw] |
Mortality |
|
N* |
Males |
|
50 |
0/1 |
250 |
0/1 |
1250 |
1/1 |
5000 |
1/1 |
Females |
|
50 |
0/1 |
250 |
1/1 |
1250 |
1/1 |
5000 |
1/1 |
* N = Number of animals / number of animals used
The mortalities indicated a LD50 in the range 250 - 1250 mg/kg bw.
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: Acute Oral 4, H302
- Executive summary:
The study was performed in year 1982 according to the standard acute Method.
This study was undertaken to determine the oral median lethal dose (LD50) of test article LZ 754 in Wistar rats.
The LD50 was calculated using a probit method. The calculated value for male and female rats is 835 mg/kg bw.
Therefore, the test item is classified as Acute Tox Oral 4, H302 according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.